Market Currents
The FDA reportedly approves GlaxoSmithKline's (GSK) Menhibrix children's meningitis vaccine. The...
-
Thursday, June 14, 2012, 5:14 PM ETThe FDA reportedly approves GlaxoSmithKline's (GSK) Menhibrix children's meningitis vaccine. The vaccine is meant for children aged from six weeks to 18 months and targets two types of bacteria that can cause meningitis, meningococcal disease and Hib disease.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
